Patent Application
20230276691
The present disclosure generally relates to organometallic compounds and formulations and their various uses including as emitters in devices such as organic light emitting diodes and related electronic devices.
Opto-electronic devices that make use of organic materials are becoming increasingly desirable for various reasons. Many of the materials used to make such devices are relatively inexpensive, so organic opto-electronic devices have the potential for cost advantages over inorganic devices. In addition, the inherent properties of organic materials, such as their flexibility, may make them well suited for particular applications such as fabrication on a flexible substrate. Examples of organic opto-electronic devices include organic light emitting diodes/devices (OLEDs), organic phototransistors, organic photovoltaic cells, and organic photodetectors. For OLEDs, the organic materials may have performance advantages over conventional materials.
OLEDs make use of thin organic films that emit light when voltage is applied across the device. OLEDs are becoming an increasingly interesting technology for use in applications such as flat panel displays, illumination, and backlighting.
One application for phosphorescent emissive molecules is a full color display. Industry standards for such a display call for pixels adapted to emit particular colors, referred to as “saturated” colors. In particular, these standards call for saturated red, green, and blue pixels. Alternatively, the OLED can be designed to emit white light. In conventional liquid crystal displays emission from a white backlight is filtered using absorption filters to produce red, green and blue emission. The same technique can also be used with OLEDs. The white OLED can be either a single emissive layer (EML) device or a stack structure. Color may be measured using CIE coordinates, which are well known to the art.
Dibenzofuran, azadibenzofuran and its dibnezothiophene analogs can be useful as ligands in phosphorescent OLED. Fluorinated dibenzofuran or dibenzothiophene groups are found to have similar or better photophysical properties. For example, DFT data has shown that adding a fluorine or fluorinated substituent produces photoluminescence (PL) emission spectra with narrower lineshape. In addition, we believe adding fluorine or fluorinated moiety may improve sublimation profile of an emitter.
In one aspect, the present disclosure provides a compound of Formula Ir(LA)m(LC)n or Pt(LA)(LB); wherein m and n are each independently 1 or 2; wherein m+n=3;
wherein LA has a structure of Formula I:
wherein:
the moiety A is a polycyclic fused ring structure comprising two or more fused 5-membered and/or 6-membered aromatic rings;
Y is selected from the group consisting of BR, BRR′, NR, PR, P(O)R, O, S, Se, C═O, C═S, C═Se, C═NR, C═CRR′, S═O, SO2, CRR′, SiRR′, and GeRR′;
RA, RB, and RC each independently represents mono to the maximum allowable substitution, or no substitution;
at least one RC1, RC2, RB or RC is a fluorine atom or a fluoroalkyl group containing at least two fluorine;
at least one of RC1 and RC2 is an alkyl, silyl, cycloalkyl, aryl, heteroaryl group, or their combinations;
LA is coordinated to Ir or Pt through the indicated dashed lines to comprise a 5-membered chelate ring;
LC is selected from the group consisting of:
wherein each of RC1, RC2, R, R′, RA, RB, RC, R1, R2, R3, R4, R5, R6, R7, Ra2, Rb2, Rc2, Rd2, and Re2 is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, selenyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein LC is a bidentate ligand; and wherein any two substituents can be joined or fused together to form a ring; and
LA and LB may be joined together to form a tetradentate ligand.
In another aspect, the present disclosure provides a formulation comprising the compound of Formula Ir(LA)m(LC)n or Pt(LA)(LB) described herein.
In yet another aspect, the present disclosure provides an OLED having an organic layer comprising the compound of Formula Ir(LA)m(LC)n or Pt(LA)(LB) described herein.
In yet another aspect, the present disclosure provides a consumer product comprising an OLED with an organic layer comprising the compound of Formula Ir(LA)m(LC)n or Pt(LA)(LB) described herein.
Unless otherwise specified, the below terms used herein are defined as follows:
As used herein, the term “organic” includes polymeric materials as well as small molecule organic materials that may be used to fabricate organic opto-electronic devices. “Small molecule” refers to any organic material that is not a polymer, and “small molecules” may actually be quite large. Small molecules may include repeat units in some circumstances. For example, using a long chain alkyl group as a substituent does not remove a molecule from the “small molecule” class. Small molecules may also be incorporated into polymers, for example as a pendent group on a polymer backbone or as a part of the backbone. Small molecules may also serve as the core moiety of a dendrimer, which consists of a series of chemical shells built on the core moiety. The core moiety of a dendrimer may be a fluorescent or phosphorescent small molecule emitter. A dendrimer may be a “small molecule,” and it is believed that all dendrimers currently used in the field of OLEDs are small molecules.
As used herein, “top” means furthest away from the substrate, while “bottom” means closest to the substrate. Where a first layer is described as “disposed over” a second layer, the first layer is disposed further away from substrate. There may be other layers between the first and second layer, unless it is specified that the first layer is “in contact with” the second layer. For example, a cathode may be described as “disposed over” an anode, even though there are various organic layers in between.
As used herein, “solution processable” means capable of being dissolved, dispersed, or transported in and/or deposited from a liquid medium, either in solution or suspension form.
A ligand may be referred to as “photoactive” when it is believed that the ligand directly contributes to the photoactive properties of an emissive material. A ligand may be referred to as “ancillary” when it is believed that the ligand does not contribute to the photoactive properties of an emissive material, although an ancillary ligand may alter the properties of a photoactive ligand.
As used herein, and as would be generally understood by one skilled in the art, a first “Highest Occupied Molecular Orbital” (HOMO) or “Lowest Unoccupied Molecular Orbital” (LUMO) energy level is “greater than” or “higher than” a second HOMO or LUMO energy level if the first energy level is closer to the vacuum energy level. Since ionization potentials (IP) are measured as a negative energy relative to a vacuum level, a higher HOMO energy level corresponds to an IP having a smaller absolute value (an IP that is less negative). Similarly, a higher LUMO energy level corresponds to an electron affinity (EA) having a smaller absolute value (an EA that is less negative). On a conventional energy level diagram, with the vacuum level at the top, the LUMO energy level of a material is higher than the HOMO energy level of the same material. A “higher” HOMO or LUMO energy level appears closer to the top of such a diagram than a “lower” HOMO or LUMO energy level.
As used herein, and as would be generally understood by one skilled in the art, a first work function is “greater than” or “higher than” a second work function if the first work function has a higher absolute value. Because work functions are generally measured as negative numbers relative to vacuum level, this means that a “higher” work function is more negative. On a conventional energy level diagram, with the vacuum level at the top, a “higher” work function is illustrated as further away from the vacuum level in the downward direction. Thus, the definitions of HOMO and LUMO energy levels follow a different convention than work functions.
The terms “halo,” “halogen,” and “halide” are used interchangeably and refer to fluorine, chlorine, bromine, and iodine.
The term “acyl” refers to a substituted carbonyl radical (C(O)—Rs).
The term “ester” refers to a substituted oxycarbonyl (—O—C(O)—Rs or —C(O)—O—Rs) radical.
The term “ether” refers to an —ORs radical.
The terms “sulfanyl” or “thio-ether” are used interchangeably and refer to a —SRs radical.
The term “selenyl” refers to a —SeRs radical.
The term “sulfinyl” refers to a —S(O)—Rs radical.
The term “sulfonyl” refers to a —SO2—Rs radical.
The term “phosphino” refers to a —P(Rs)3 radical, wherein each Rs can be same or different.
The term “silyl” refers to a —Si(Rs)3 radical, wherein each Rs can be same or different.
The term “germyl” refers to a —Ge(Rs)3 radical, wherein each Rs can be same or different.
The term “boryl” refers to a —B(Rs)2 radical or its Lewis adduct —B(Rs)3 radical, wherein Rs can be same or different.
In each of the above, Rs can be hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, and combination thereof. Preferred Rs is selected from the group consisting of alkyl, cycloalkyl, aryl, heteroaryl, and combination thereof.
The term “alkyl” refers to and includes both straight and branched chain alkyl radicals. Preferred alkyl groups are those containing from one to fifteen carbon atoms and includes methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, and the like. Additionally, the alkyl group may be optionally substituted.
The term “cycloalkyl” refers to and includes monocyclic, polycyclic, and spiro alkyl radicals. Preferred cycloalkyl groups are those containing 3 to 12 ring carbon atoms and includes cyclopropyl, cyclopentyl, cyclohexyl, bicyclo[3.1.1]heptyl, spiro[4.5]decyl, spiro[5.5]undecyl, adamantyl, and the like. Additionally, the cycloalkyl group may be optionally substituted.
The terms “heteroalkyl” or “heterocycloalkyl” refer to an alkyl or a cycloalkyl radical, respectively, having at least one carbon atom replaced by a heteroatom. Optionally the at least one heteroatom is selected from O, S, N, P, B, Si and Se, preferably, O, S or N. Additionally, the heteroalkyl or heterocycloalkyl group may be optionally substituted.
The term “alkenyl” refers to and includes both straight and branched chain alkene radicals. Alkenyl groups are essentially alkyl groups that include at least one carbon-carbon double bond in the alkyl chain. Cycloalkenyl groups are essentially cycloalkyl groups that include at least one carbon-carbon double bond in the cycloalkyl ring. The term “heteroalkenyl” as used herein refers to an alkenyl radical having at least one carbon atom replaced by a heteroatom. Optionally the at least one heteroatom is selected from O, S, N, P, B, Si, and Se, preferably, O, S, or N. Preferred alkenyl, cycloalkenyl, or heteroalkenyl groups are those containing two to fifteen carbon atoms. Additionally, the alkenyl, cycloalkenyl, or heteroalkenyl group may be optionally substituted.
The term “alkynyl” refers to and includes both straight and branched chain alkyne radicals. Alkynyl groups are essentially alkyl groups that include at least one carbon-carbon triple bond in the alkyl chain. Preferred alkynyl groups are those containing two to fifteen carbon atoms. Additionally, the alkynyl group may be optionally substituted.
The terms “aralkyl” or “arylalkyl” are used interchangeably and refer to an alkyl group that is substituted with an aryl group. Additionally, the aralkyl group may be optionally substituted.
The term “heterocyclic group” refers to and includes aromatic and non-aromatic cyclic radicals containing at least one heteroatom. Optionally the at least one heteroatom is selected from O, S, N, P, B, Si, and Se, preferably, O, S, or N. Hetero-aromatic cyclic radicals may be used interchangeably with heteroaryl. Preferred hetero-non-aromatic cyclic groups are those containing 3 to 7 ring atoms which includes at least one hetero atom, and includes cyclic amines such as morpholino, piperidino, pyrrolidino, and the like, and cyclic ethers/thio-ethers, such as tetrahydrofuran, tetrahydropyran, tetrahydrothiophene, and the like. Additionally, the heterocyclic group may be optionally substituted.
The term “aryl” refers to and includes both single-ring aromatic hydrocarbyl groups and polycyclic aromatic ring systems. The polycyclic rings may have two or more rings in which two carbons are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is an aromatic hydrocarbyl group, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. Preferred aryl groups are those containing six to thirty carbon atoms, preferably six to twenty carbon atoms, more preferably six to twelve carbon atoms. Especially preferred is an aryl group having six carbons, ten carbons or twelve carbons. Suitable aryl groups include phenyl, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene, preferably phenyl, biphenyl, triphenyl, triphenylene, fluorene, and naphthalene. Additionally, the aryl group may be optionally substituted.
The term “heteroaryl” refers to and includes both single-ring aromatic groups and polycyclic aromatic ring systems that include at least one heteroatom. The heteroatoms include, but are not limited to O, S, N, P, B, Si, and Se. In many instances, O, S, or N are the preferred heteroatoms. Hetero-single ring aromatic systems are preferably single rings with 5 or 6 ring atoms, and the ring can have from one to six heteroatoms. The hetero-polycyclic ring systems can have two or more rings in which two atoms are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is a heteroaryl, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. The hetero-polycyclic aromatic ring systems can have from one to six heteroatoms per ring of the polycyclic aromatic ring system. Preferred heteroaryl groups are those containing three to thirty carbon atoms, preferably three to twenty carbon atoms, more preferably three to twelve carbon atoms. Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine, preferably dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, triazine, benzimidazole, 1,2-azaborine, 1,3-azaborine, 1,4-azaborine, borazine, and aza-analogs thereof. Additionally, the heteroaryl group may be optionally substituted.
Of the aryl and heteroaryl groups listed above, the groups of triphenylene, naphthalene, anthracene, dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, pyrazine, pyrimidine, triazine, and benzimidazole, and the respective aza-analogs of each thereof are of particular interest.
The terms alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aralkyl, heterocyclic group, aryl, and heteroaryl, as used herein, are independently unsubstituted, or independently substituted, with one or more general substituents.
In many instances, the general substituents are selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, selenyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In some instances, the preferred general substituents are selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, boryl, and combinations thereof.
In some instances, the more preferred general substituents are selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, alkoxy, aryloxy, amino, silyl, aryl, heteroaryl, sulfanyl, and combinations thereof.
In yet other instances, the most preferred general substituents are selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof.
The terms “substituted” and “substitution” refer to a substituent other than H that is bonded to the relevant position, e.g., a carbon or nitrogen. For example, when R1 represents mono-substitution, then one R1 must be other than H (i.e., a substitution). Similarly, when R1 represents di-substitution, then two of R1 must be other than H. Similarly, when R1 represents zero or no substitution, R1, for example, can be a hydrogen for available valencies of ring atoms, as in carbon atoms for benzene and the nitrogen atom in pyrrole, or simply represents nothing for ring atoms with fully filled valencies, e.g., the nitrogen atom in pyridine. The maximum number of substitutions possible in a ring structure will depend on the total number of available valencies in the ring atoms.
As used herein, “combinations thereof” indicates that one or more members of the applicable list are combined to form a known or chemically stable arrangement that one of ordinary skill in the art can envision from the applicable list. For example, an alkyl and deuterium can be combined to form a partial or fully deuterated alkyl group; a halogen and alkyl can be combined to form a halogenated alkyl substituent; and a halogen, alkyl, and aryl can be combined to form a halogenated arylalkyl. In one instance, the term substitution includes a combination of two to four of the listed groups. In another instance, the term substitution includes a combination of two to three groups. In yet another instance, the term substitution includes a combination of two groups. Preferred combinations of substituent groups are those that contain up to fifty atoms that are not hydrogen or deuterium, or those which include up to forty atoms that are not hydrogen or deuterium, or those that include up to thirty atoms that are not hydrogen or deuterium. In many instances, a preferred combination of substituent groups will include up to twenty atoms that are not hydrogen or deuterium.
The “aza” designation in the fragments described herein, i.e. aza-dibenzofuran, aza-dibenzothiophene, etc. means that one or more of the C—H groups in the respective aromatic ring can be replaced by a nitrogen atom, for example, and without any limitation, azatriphenylene encompasses both dibenzo[f,h]quinoxaline and dibenzo[f,h]quinoline. One of ordinary skill in the art can readily envision other nitrogen analogs of the aza-derivatives described above, and all such analogs are intended to be encompassed by the terms as set forth herein.
As used herein, “deuterium” refers to an isotope of hydrogen. Deuterated compounds can be readily prepared using methods known in the art. For example, U.S. Pat. No. 8,557,400, Patent Pub. No. WO 2006/095951, and U.S. Pat. Application Pub. No. US 2011/0037057, which are hereby incorporated by reference in their entireties, describe the making of deuterium-substituted organometallic complexes. Further reference is made to Ming Yan, et al., Tetrahedron 2015, 71, 1425-30 and Atzrodt et al., Angew. Chem. Int. Ed. (Reviews) 2007, 46, 7744-65, which are incorporated by reference in their entireties, describe the deuteration of the methylene hydrogens in benzyl amines and efficient pathways to replace aromatic ring hydrogens with deuterium, respectively.
It is to be understood that when a molecular fragment is described as being a substituent or otherwise attached to another moiety, its name may be written as if it were a fragment (e.g. phenyl, phenylene, naphthyl, dibenzofuryl) or as if it were the whole molecule (e.g. benzene, naphthalene, dibenzofuran). As used herein, these different ways of designating a substituent or attached fragment are considered to be equivalent.
In some instance, a pair of adjacent substituents can be optionally joined or fused into a ring. The preferred ring is a five, six, or seven-membered carbocyclic or heterocyclic ring, includes both instances where the portion of the ring formed by the pair of substituents is saturated and where the portion of the ring formed by the pair of substituents is unsaturated. As used herein, “adjacent” means that the two substituents involved can be on the same ring next to each other, or on two neighboring rings having the two closest available substitutable positions, such as 2,2′ positions in a biphenyl, or 1,8 position in a naphthalene, as long as they can form a stable fused ring system.
In one aspect, the present disclosure provides a compound of Formula Ir(LA)m(LC)n or Pt(LA)(LB); wherein:
m and n are each independently 1 or 2;
m+n=3; and
LA has a structure of Formula I:
wherein:
the moiety A is a polycyclic fused ring structure comprising two or more fused 5-membered and/or 6-membered aromatic rings;
Y is selected from the group consisting of BR, BRR′, NR, PR, P(O)R, O, S, Se, C═O, C═S, C═Se, C═NR, C═CRR′, S═O, SO2, CRR′, SiRR′, and GeRR′;
RA, RB, and RC each independently represents mono to the maximum allowable substitution, or no substitution;
at least one RC1, RC2, RB or RC is a fluorine atom or a fluoroalkyl group containing at least two fluorine;
at least one of RC1 and RC2 is an alkyl, silyl, cycloalkyl, aryl, heteroaryl group, or their combinations;
LA is coordinated to Ir or Pt through the indicated dashed lines to comprise a 5-membered chelate ring;
LC is selected from the group consisting of:
wherein each of RC1, RC2, R, R′, RA, RB, RC, R1, R2, R3, R4, R5, R6, R7, Ra2, Rb2, Rc2, Rd2, and Re2 is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, selenyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;
wherein LB is a bidentate ligand;
wherein any two substituents can be joined or fused together to form a ring; and
wherein LA and LB may be joined together to form a tetradentate ligand.
In some embodiments of the compound, each of RC1, RC2, R, R′, RA, RB, RC, R1, R2, R3, R4, R5, R6, R7, Ra2, Rb2, Rc2, Rd2, and Re2 is independently a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, selenyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof.
In some embodiments, the moiety A is a bicyclic fused ring structure comprising one 5-membered aromatic ring and one 6-membered aromatic ring. In some embodiments, the moiety A is a bicyclic fused ring structure comprising one 5-membered heterocyclic aromatic ring. In some embodiments, the moiety A is a bicyclic fused ring structure comprising one 5-membered heterocyclic aromatic ring whose hetero-atom is S.
In some embodiments, the moiety A is a bicyclic fused ring structure comprising two 6-membered aromatic rings. In some embodiments, the moiety A is a bicyclic fused ring structure comprising two 6-membered aromatic rings with exactly two ring N atoms. In some embodiments, the moiety A is a bicyclic fused ring structure comprising two 6-membered aromatic rings with two or more ring N atoms. In some embodiments, the moiety A is a tricyclic fused ring structure comprising three 6-membered aromatic rings.
In some embodiments, the moiety A is a tricyclic fused ring structure comprising two 6-membered aromatic rings and one 5-membered aromatic ring.
In some embodiments, moiety A is a polycyclic fused ring structure comprising at least one of the following: phenyl, pyridine, pyrimidine, pyridazine, pyrazine, triazine, imidazole, pyrazole, pyrrole, oxazole, furan, thiophene, thiazole, naphthalene, quinoline, isoquinoline, quinazoline, benzofuran, benzoxazole, benzothiophene, benzothiazole, benzoselenophene, indene, indole, benzimidazole, carbazole, dibenzofuran, dibenzothiophene, quinoxaline, phthalazine, phenanthrene, phenanthridine, fluorene, naphtho[2,3-b]thiophene, and naphtho[2,3-b]furan.
In some embodiments, the moiety A is a polycyclic fused ring structure comprising four or more fused aromatic rings. In some embodiments, the moiety A is a polycyclic fused ring structure comprising five or more fused aromatic rings. In some embodiments, the moiety A is a polycyclic fused ring structure comprising at least one phenyl ring. In some embodiments, the moiety A is a polycyclic fused ring structure comprising at least two phenyl rings. In some embodiments, the moiety A is a polycyclic fused ring structure comprising at least one thiophene or thiazole ring.
In some embodiments, the moiety A can be selected from the group consisting of naphthalene, quinoline, isoquinoline, quinazoline, benzofuran, benzoxazole, benzothiophene, benzothiazole, benzoselenophene, indene, indole, benzimidazole, carbazole, dibenzofuran, dibenzothiophene, quinoxaline, phthalazine, phenanthrene, phenanthridine, fluorene, and their aza variants.
In some embodiments, each of RC1 and RC2 that is an alkyl, silyl, cycloalkyl, aryl, heteroaryl group, or their combinations, can be further partially or fully fluorinated or deuterated. In some embodiments, at least one RA is an alkyl. In some embodiments, at least one RA is partially or fully fluorinated. In some embodiments, at least one RA is a fluorine atom.
In some embodiments, Y is O.
In some embodiments of the compound, LC is Formula A
In some embodiments, R7 in Formula A is H. In some embodiments, R2 and R5 in Formula A are each H. In some embodiments, R2 and R5 in Formula A are each a methyl. In some embodiments, at least one of R1, R2, R3, R4, R5, R6, and R7 in Formula A is partially or fully fluorinated. In some embodiments, at least one of R1, R2, R3, R4, R5, R6, and R7 in Formula A is a fluorine.
In some embodiments of the compound, the ligand LA is selected from the group consisting of the following structures (LIST A1):
In some embodiments of the compound, the ligand LA is selected from the group consisting of the structures LAi-o, wherein i is an integer from 1 to 1812, and o is an integer from 1 to 71, and the structure of each LAi-o is as defined below in LIST 1:
wherein for each LAi, RA, RB, RC, RC1, and RC2 are defined in the following table.
wherein R1 to R50 have the following structures:
In some embodiments of the compound, the ligand LA is selected from LAw, wherein w is an integer from 1 to 36, and each LAw is defined in the following LIST 2:
In some embodiments, the compound has the formula Pt(LA)(LB), wherein LA and LB are connected to form a tetradentate ligand.
In some embodiments, the compound has the formula Ir(LA)m(LC)n; and LC is a substituted or unsubstituted acetylacetonate.
In some embodiments, the compound has the formula Pt(LA)(LB); and LB is selected from the group consisting of:
wherein:
T is selected from the group consisting of B, Al, Ga, and In;
K1′ is a direct bond or is selected from the group consisting of NRe, PRe, O, S, and Se;
each Y1 to Y13 are independently selected from the group consisting of carbon and nitrogen;
Y′ is selected from the group consisting of BRe, BReRf, NRe, PRe, P(O)Re, O, S, Se, C═O, C═S, C═Se, C═NRe, C═CReRf, S═O, SO2, CReRf, SiReRf, and GeReRf;
Re and Rf can be fused or joined to form a ring;
each Ra, Rb, Rc, and Rd can independently represent from mono to the maximum possible number of substitutions, or no substitution;
each Ra1, Rb1, Rc1, Rd1, Ra, Rb, Re, Rd, Re, and Rf is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; and
any two Ra1, Rb1, Rc1, Rd1, Ra, Rb, Re, and Rd can be fused or joined to form a ring or form a multidentate ligand.
In some embodiments, the compound has the formula Pt(LA)(LB), wherein LB is selected from the group consisting of:
wherein:
Ra′, Rb′, Rc′, Rd′, and Re′ each independently represent zero, mono, or up to a maximum allowed substitution to its associated ring;
Ra1, Rb1, Rc1, Ra′, Rb′, Rc′, Rd′, and Re′ each independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; and
any two Ra1, Rb1, Rc1, Ra′, Rb′, Rc′, Rd′, and Re′ can be fused or joined to form a ring or form a multidentate ligand.
In some embodiments of the compound, LA can be selected from the structures LAi-o, wherein i is an integer from 1 to 1812; o is an integer from 1 to 71, wherein:
when the compound has formula Ir(LAi-o)(LCj-I)2, the compound is selected from the group consisting of Ir(LA1-I)(LC1-I)2 to Ir(LA1812-71)(LC1416-I)2;
when the compound has formula Ir(LAi-o)(LCj-II)2, the compound is selected from the group consisting of Ir(LA1-I)(LC1-II)2 to Ir(LA1812-71)(LC1416-II)2;
when the compound has formula Ir(LAi-o)2(LC), the compound is selected from the group consisting of Ir(LA1-I)2(LC1-I) to Ir(LA1812-71)2(LC1416-I);
when the compound has formula Ir(LAi-o)2(LCj-II), the compound is selected from the group consisting of Ir(LA1-I)2(LC1-II) to Ir(LA1812_71)2(LC1416-11);
wherein LC can be LCj-I or LCj-II, wherein j is an integer from 1 to 1416, wherein each LCj-I has a structure based on formula
and
each LCj-II has a structure based on formula
wherein for each LCj in LCj-I and LCj-II, R201 and R202 are each independently defined as provided in the following LIST 4:
wherein RD1 to RD246 have the following structures:
In some embodiments of the compound, the compound is selected from the group consisting of only those compounds having LCj-I or LCj-II ligand whose corresponding R201 and R202 are defined to be one of the following structures: RD1, RD3, RD4, RD5, RD9, RD10, RD17, RD18, RD20, RD22, RD37, RD40, RD41, RD42, RD43, RD48, RD49, RD50, RD54, RD55, RD58, RD59, RD78, RD79, RD81, RD87, RD88, RD89, RD93, RD116, RD117, RD118, RD119, RD120, RD133, RD134, RD135, RD136, RD143, RD144, RD145, RD146, RD147, RD149, RD151, RD154, RD155, RD161, RD175 RD190, RD193, RD200, RD210, RD206, RD210, RD214, RD215, RD216, RD218, RD219, RD220, RD227, RD237, RD241, RD242, RD245, and RD246.
In some embodiments of the compound, the compound is selected from the group consisting of only those compounds having LCj-I or LCj-II ligand whose corresponding R201 and R202 are defined to be one of selected from the following structures RD1, RD3, RD4, RD5, RD9, RD10, RD17, RD22, RD43, RD50, RD78, RD116, RD118, RD133, RD134, RD135, RD136, RD143, RD144, RD145, RD146, RD149, RD151, RD154, RD155, RD190, RD193, RD200, RD201, RD206, RD210, RD214, RD215, RD216, RD218, RD219, RD220, RD227, RD237, RD241, RD242, RD245, and RD246.
In some embodiments of the compound, the compound is selected from the group consisting of only those compounds having one of the following structures in LIST 5 for the LCj-I ligand:
In some embodiments, the compound can be Ir(LA)2(LC), or Ir(LA)(LC)2. In some of these embodiments, LA can have a Formula I as defined herein. In some of these embodiments, LC is defined herein. In some of these embodiments, LA can be selected from the group consisting of LIST A1 as defined herein. In some of these embodiments, LA can be LAs shown in LIST 2 defined herein. In some of these embodiments, the compound can be Ir(LAi-o)2(LCj-I), Ir(LAi-o)(LCj-II)2, Ir(LAi-o)2(LCj-II), Ir(LAi-o)(LCj-II)2, Ir(LAw)2(LCj-I), Ir(LAw)(LCj-I)2, Ir(LAw)2(LCj-II), or Ir(LAw)(LCj-II)2,
In some embodiments, the compound is selected from the group consisting of the structures in the following LIST 6:
wherein TMS is tetramethylsilane.
In some embodiments, the compound has Formula II
wherein:
moieties E and F are each independently monocyclic or polycyclic ring structure comprising 5-membered and/or 6-membered carbocyclic or heterocyclic rings;
Z1 and Z2 are each independently C or N;
K1, K2, K3, and K4 are each independently selected from the group consisting of a direct bond, O, and S, wherein at least two of them are direct bonds;
L1, L2, and L3 are each independently selected from the group consisting of a single bond, absent a bond, BR, BRR′, NR, PR, P(O)R, O, S, Se, C═O, C═S, C═Se, C═NR′, C═CRR′, S═O, SO2, CR, CRR′, SiRR′, and GeRR′, wherein at least one of L1 and L2 is present;
RE and RF each independently represent zero, mono, or up to a maximum allowed number of substitutions to its associated ring;
each of R′, R″, RE, and RF is independently a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof; and
any two R, R′, RA, RB, RC, RE, and RF can be joined or fused together to form a ring where chemically feasible.
In some embodiments, the moiety E and moiety F in Formula II are both 6-membered aromatic rings. In some embodiments, the moiety F in Formula II is a 5-membered or 6-membered heteroaromatic ring.
In some embodiments, L1 in Formula II is O or CR′R″. In some embodiments of the compound having Formula II, Z2 is N and Z1 is C. In some embodiments of the compound having Formula II, Z2 is C and Z1 is N.
In some embodiments of the compound having Formula II, L2 is a direct bond. In some embodiments, L2 is NR′. In some embodiments of the compound having Formula II, K1, K2, K3, and K4 are all direct bonds. In some embodiments, one of K1, K2, K3, and K4 is O.
In some embodiments, the compound may be selected from the group consisting of compounds having the formula of Pt(LA′)(Ly):
wherein LA′ is selected from the group consisting of the structure shown below:
wherein Ly is selected from the group consisting of the structures shown below:
wherein each RE, RF, RX, and RY is independently selected from the list consisting of:
In some embodiments, the compound may be selected from the group consisting of the compounds having the formula of Pt(LA′)(Ly):
wherein LA′ is selected from the group consisting of the structures shown below:
wherein Ly is selected from the group consisting of the structures shown below:
wherein i, j, k, s, t, and u, are each independently an integer from i to 135,
wherein R1 to R135 have the following structures:
In some embodiments, the compound is selected from the group consisting of:
In some embodiments, the compound having a ligand LA of Formula I described herein can be at least 30% deuterated, at least 40% deuterated, at least 50% deuterated, at least 60% deuterated, at least 70% deuterated, at least 80% deuterated, at least 90% deuterated, at least 95% deuterated, at least 99% deuterated, or 100% deuterated. As used herein, percent deuteration has its ordinary meaning and includes the percent of possible hydrogen atoms (e.g., positions that are hydrogen, deuterium, or halogen) that are replaced by deuterium atoms.
In another aspect, the present disclosure also provides an OLED device comprising a first organic layer that contains a compound as disclosed in the above compounds section of the present disclosure.
In some embodiments, the OLED comprises: an anode; a cathode; and an organic layer disposed between the anode and the cathode, where the organic layer comprises a compound of Formula Ir(LA)m(LC)n or Pt(LA)(LB); wherein:
m and n are each independently 1 or 2;
m+n=3; and
LA has a structure of Formula I:
wherein:
LA is coordinated to Ir through the indicated dashed lines to comprise a 5-membered chelate ring;
LC is selected from the group consisting of:
wherein each of RC1, RC2, R, R′, RA, RB, RC, R1, R2, R3, R4, R5, R6, R7, Ra2, Rb2, Rc2, Rd2, and Re2 is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, selenyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;
wherein LB is a bidentate ligand;
LA and LB may be joined together to form a tetradentate ligand; and
wherein any two substituents can be joined or fused together to form a ring.
In some embodiments of the OLED, the compound is a sensitizer, and the OLED further comprises an acceptor selected from the group consisting of a fluorescent emitter, a delayed fluorescence emitter, and combination thereof.
In some embodiments, the organic layer may be an emissive layer and the compound as described herein may be an emissive dopant or a non-emissive dopant.
In some embodiments, the organic layer may further comprise a host, wherein the host comprises a triphenylene containing benzo-fused thiophene or benzo-fused furan, wherein any substituent in the host is an unfused substituent independently selected from the group consisting of CnH2n+1, OCnH2n+1, OAr1, N(CnH2n+1)2, N(Ar1)(Ar2), CH═CH—CnH2n+1, C≡CCnH2n+1, Ar1, Ar1—Ar2, CnH2n—Ar1, or no substitution, wherein n is from 1 to 10; and wherein Ar1 and Ar2 are independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof.
In some embodiments, the organic layer may further comprise a host, wherein host comprises at least one chemical group selected from the group consisting of triphenylene, carbazole, dibenzothiphene, dibenzofuran, dibenzoselenophene, azatriphenylene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene.
In some embodiments, the host may be selected from the HOST Group consisting of:
and combinations thereof.
In some embodiments, the organic layer may further comprise a host, wherein the host comprises a metal complex.
In some embodiments, the compound as described herein may be a sensitizer; wherein the device may further comprise an acceptor; and wherein the acceptor may be selected from the group consisting of fluorescent emitter, delayed fluorescence emitter, and combination thereof.
In yet another aspect, the OLED of the present disclosure may also comprise an emissive region containing a compound as disclosed in the above compounds section of the present disclosure.
In some embodiments, the emissive region can comprise a compound of Formula Ir(LA)m(LC)n or Pt(LA)(LB);
wherein:
m and n are each independently 1 or 2;
m+n=3; and
LA has a structure of Formula I:
wherein:
LA is coordinated to Ir through the indicated dashed lines to comprise a 5-membered chelate ring;
LC is selected from the group consisting of:
wherein each of RC1, RC2, R, R′, RA, RB, RC, R1, R2, R3, R4, R5, R6, R7, Ra2, Rb2, Rc2, Rd2, and Re2 is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, selenyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;
wherein LB is a bidentate ligand;
LA and LB may be joined together to form a tetradentate ligand; and
wherein any two substituents can be joined or fused together to form a ring.
In some embodiments, at least one of the anode, the cathode, or a new layer disposed over the organic emissive layer functions as an enhancement layer. The enhancement layer comprises a plasmonic material exhibiting surface plasmon resonance that non-radiatively couples to the emitter material and transfers excited state energy from the emitter material to non-radiative mode of surface plasmon polariton. The enhancement layer is provided no more than a threshold distance away from the organic emissive layer, wherein the emitter material has a total non-radiative decay rate constant and a total radiative decay rate constant due to the presence of the enhancement layer and the threshold distance is where the total non-radiative decay rate constant is equal to the total radiative decay rate constant. In some embodiments, the OLED further comprises an outcoupling layer. In some embodiments, the outcoupling layer is disposed over the enhancement layer on the opposite side of the organic emissive layer. In some embodiments, the outcoupling layer is disposed on opposite side of the emissive layer from the enhancement layer but still outcouples energy from the surface plasmon mode of the enhancement layer. The outcoupling layer scatters the energy from the surface plasmon polaritons. In some embodiments this energy is scattered as photons to free space. In other embodiments, the energy is scattered from the surface plasmon mode into other modes of the device such as but not limited to the organic waveguide mode, the substrate mode, or another waveguiding mode. If energy is scattered to the non-free space mode of the OLED other outcoupling schemes could be incorporated to extract that energy to free space. In some embodiments, one or more intervening layer can be disposed between the enhancement layer and the outcoupling layer. The examples for interventing layer(s) can be dielectric materials, including organic, inorganic, perovskites, oxides, and may include stacks and/or mixtures of these materials.
The enhancement layer modifies the effective properties of the medium in which the emitter material resides resulting in any or all of the following: a decreased rate of emission, a modification of emission line-shape, a change in emission intensity with angle, a change in the stability of the emitter material, a change in the efficiency of the OLED, and reduced efficiency roll-off of the OLED device. Placement of the enhancement layer on the cathode side, anode side, or on both sides results in OLED devices which take advantage of any of the above-mentioned effects. In addition to the specific functional layers mentioned herein and illustrated in the various OLED examples shown in the figures, the OLEDs according to the present disclosure may include any of the other functional layers often found in OLEDs.
The enhancement layer can be comprised of plasmonic materials, optically active metamaterials, or hyperbolic metamaterials. As used herein, a plasmonic material is a material in which the real part of the dielectric constant crosses zero in the visible or ultraviolet region of the electromagnetic spectrum. In some embodiments, the plasmonic material includes at least one metal. In such embodiments the metal may include at least one of Ag, Al, Au, Ir, Pt, Ni, Cu, W, Ta, Fe, Cr, Mg, Ga, Rh, Ti, Ru, Pd, In, Bi, Ca alloys or mixtures of these materials, and stacks of these materials. In general, a metamaterial is a medium composed of different materials where the medium as a whole acts differently than the sum of its material parts. In particular, we define optically active metamaterials as materials which have both negative permittivity and negative permeability. Hyperbolic metamaterials, on the other hand, are anisotropic media in which the permittivity or permeability are of different sign for different spatial directions. Optically active metamaterials and hyperbolic metamaterials are strictly distinguished from many other photonic structures such as Distributed Bragg Reflectors (“DBRs”) in that the medium should appear uniform in the direction of propagation on the length scale of the wavelength of light. Using terminology that one skilled in the art can understand: the dielectric constant of the metamaterials in the direction of propagation can be described with the effective medium approximation. Plasmonic materials and metamaterials provide methods for controlling the propagation of light that can enhance OLED performance in a number of ways.
In some embodiments, the enhancement layer is provided as a planar layer. In other embodiments, the enhancement layer has wavelength-sized features that are arranged periodically, quasi-periodically, or randomly, or sub-wavelength-sized features that are arranged periodically, quasi-periodically, or randomly. In some embodiments, the wavelength-sized features and the sub-wavelength-sized features have sharp edges.
In some embodiments, the outcoupling layer has wavelength-sized features that are arranged periodically, quasi-periodically, or randomly, or sub-wavelength-sized features that are arranged periodically, quasi-periodically, or randomly. In some embodiments, the outcoupling layer may be composed of a plurality of nanoparticles and in other embodiments the outcoupling layer is composed of a plurality of nanoparticles disposed over a material. In these embodiments the outcoupling may be tunable by at least one of varying a size of the plurality of nanoparticles, varying a shape of the plurality of nanoparticles, changing a material of the plurality of nanoparticles, adjusting a thickness of the material, changing the refractive index of the material or an additional layer disposed on the plurality of nanoparticles, varying a thickness of the enhancement layer, and/or varying the material of the enhancement layer. The plurality of nanoparticles of the device may be formed from at least one of metal, dielectric material, semiconductor materials, an alloy of metal, a mixture of dielectric materials, a stack or layering of one or more materials, and/or a core of one type of material and that is coated with a shell of a different type of material. In some embodiments, the outcoupling layer is composed of at least metal nanoparticles wherein the metal is selected from the group consisting of Ag, Al, Au, Ir, Pt, Ni, Cu, W, Ta, Fe, Cr, Mg, Ga, Rh, Ti, Ru, Pd, In, Bi, Ca, alloys or mixtures of these materials, and stacks of these materials. The plurality of nanoparticles may have additional layer disposed over them. In some embodiments, the polarization of the emission can be tuned using the outcoupling layer. Varying the dimensionality and periodicity of the outcoupling layer can select a type of polarization that is preferentially outcoupled to air. In some embodiments the outcoupling layer also acts as an electrode of the device.
In yet another aspect, the present disclosure also provides a consumer product comprising an organic light-emitting device (OLED) having an anode; a cathode; and an organic layer disposed between the anode and the cathode, wherein the organic layer may comprise a compound as disclosed in the above compounds section of the present disclosure.
In some embodiments, the consumer product comprises an OLED having an anode; a cathode; and an organic layer disposed between the anode and the cathode, wherein the organic layer can comprise a compound of Formula Ir(LA)m(Lc)n or Pt(LA)(LB); wherein m and n are each independently 1 or 2; wherein m+n=3;
wherein LA has a structure of Formula I:
wherein: the moiety A is a polycyclic fused ring structure comprising two or more fused 5-membered and/or 6-membered aromatic rings; Y is selected from the group consisting of BR, NR, PR, O, S, Se, C═O, S═O, SO2, CRR′, SiRR′, and GeRR′; RA, RB, and RC each independently represents mono to the maximum allowable substitution, or no substitution;
wherein at least one RC1, RC2, RB or RC is a fluorine atom or a fluoroalkyl group containing at least two fluorine;
wherein at least one of RC1 and RC2 is an alkyl, silyl, cycloalkyl, aryl, heteroaryl group, or their combinations;
wherein LA is coordinated to Ir through the indicated dashed lines to comprise a 5-membered chelate ring;
wherein LC is selected from the group consisting of:
wherein each of RC1, RC2, R, R′, RA, RB, RC, R1, R2, R3, R4, R5, R6, R7, Ra2, Rb2, Rc2, Ra2, and Re2 is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, selenyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;
wherein LB is a bidentate ligand;
LA and LB may be joined together to form a tetradentate ligand; and
wherein any two substituents can be joined or fused together to form a ring.
In some embodiments, the consumer product can be one of a flat panel display, a computer monitor, a medical monitor, a television, a billboard, a light for interior or exterior illumination and/or signaling, a heads-up display, a fully or partially transparent display, a flexible display, a laser printer, a telephone, a cell phone, tablet, a phablet, a personal digital assistant (PDA), a wearable device, a laptop computer, a digital camera, a camcorder, a viewfinder, a micro-display that is less than 2 inches diagonal, a 3-D display, a virtual reality or augmented reality display, a vehicle, a video wall comprising multiple displays tiled together, a theater or stadium screen, a light therapy device, and a sign.
Generally, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When a current is applied, the anode injects holes and the cathode injects electrons into the organic layer(s). The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and hole localize on the same molecule, an “exciton,” which is a localized electron-hole pair having an excited energy state, is formed. Light is emitted when the exciton relaxes via a photoemissive mechanism. In some cases, the exciton may be localized on an excimer or an exciplex. Non-radiative mechanisms, such as thermal relaxation, may also occur, but are generally considered undesirable.
Several OLED materials and configurations are described in U.S. Pat. Nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated herein by reference in their entirety.
The initial OLEDs used emissive molecules that emitted light from their singlet states (“fluorescence”) as disclosed, for example, in U.S. Pat. No. 4,769,292, which is incorporated by reference in its entirety. Fluorescent emission generally occurs in a time frame of less than 10 nanoseconds.
More recently, OLEDs having emissive materials that emit light from triplet states (“phosphorescence”) have been demonstrated. Baldo et al., “Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices,” Nature, vol. 395, 151-154, 1998; (“Baldo-I”) and Baldo et al., “Very high-efficiency green organic light-emitting devices based on electrophosphorescence,” Appl. Phys. Lett., vol. 75, No. 3, 4-6 (1999) (“Baldo-II”), are incorporated by reference in their entireties. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704 at cols. 5-6, which are incorporated by reference.
More examples for each of these layers are available. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is m-MTDATA doped with F4-TCNQ at a molar ratio of 50:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of emissive and host materials are disclosed in U.S. Pat. No. 6,303,238 to Thompson et al., which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entireties, disclose examples of cathodes including compound cathodes having a thin layer of metal such as Mg:Ag with an overlying transparent, electrically-conductive, sputter-deposited ITO layer. The theory and use of blocking layers is described in more detail in U.S. Pat. No. 6,097,147 and U.S. Patent Application Publication No. 2003/0230980, which are incorporated by reference in their entireties. Examples of injection layers are provided in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of protective layers may be found in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety.
The simple layered structure illustrated in
Structures and materials not specifically described may also be used, such as OLEDs comprised of polymeric materials (PLEDs) such as disclosed in U.S. Pat. No. 5,247,190 to Friend et al., which is incorporated by reference in its entirety. By way of further example, OLEDs having a single organic layer may be used. OLEDs may be stacked, for example as described in U.S. Pat. No. 5,707,745 to Forrest et al, which is incorporated by reference in its entirety. The OLED structure may deviate from the simple layered structure illustrated in
Unless otherwise specified, any of the layers of the various embodiments may be deposited by any suitable method. For the organic layers, preferred methods include thermal evaporation, ink-jet, such as described in U.S. Pat. Nos. 6,013,982 and 6,087,196, which are incorporated by reference in their entireties, organic vapor phase deposition (OVPD), such as described in U.S. Pat. No. 6,337,102 to Forrest et al., which is incorporated by reference in its entirety, and deposition by organic vapor jet printing (OVJP), such as described in U.S. Pat. No. 7,431,968, which is incorporated by reference in its entirety. Other suitable deposition methods include spin coating and other solution based processes. Solution based processes are preferably carried out in nitrogen or an inert atmosphere. For the other layers, preferred methods include thermal evaporation. Preferred patterning methods include deposition through a mask, cold welding such as described in U.S. Pat. Nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entireties, and patterning associated with some of the deposition methods such as ink-jet and organic vapor jet printing (OVJP). Other methods may also be used. The materials to be deposited may be modified to make them compatible with a particular deposition method. For example, substituents such as alkyl and aryl groups, branched or unbranched, and preferably containing at least 3 carbons, may be used in small molecules to enhance their ability to undergo solution processing. Substituents having 20 carbons or more may be used, and 3-20 carbons are a preferred range. Materials with asymmetric structures may have better solution processability than those having symmetric structures, because asymmetric materials may have a lower tendency to recrystallize. Dendrimer substituents may be used to enhance the ability of small molecules to undergo solution processing.
Devices fabricated in accordance with embodiments of the present disclosure may further optionally comprise a barrier layer. One purpose of the barrier layer is to protect the electrodes and organic layers from damaging exposure to harmful species in the environment including moisture, vapor and/or gases, etc. The barrier layer may be deposited over, under or next to a substrate, an electrode, or over any other parts of a device including an edge. The barrier layer may comprise a single layer, or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include compositions having a single phase as well as compositions having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate an inorganic or an organic compound or both. The preferred barrier layer comprises a mixture of a polymeric material and a non-polymeric material as described in U.S. Pat. No. 7,968,146, PCT Pat. Application Nos. PCT/US2007/023098 and PCT/US2009/042829, which are herein incorporated by reference in their entireties. To be considered a “mixture”, the aforesaid polymeric and non-polymeric materials comprising the barrier layer should be deposited under the same reaction conditions and/or at the same time. The weight ratio of polymeric to non-polymeric material may be in the range of 95:5 to 5:95. The polymeric material and the non-polymeric material may be created from the same precursor material. In one example, the mixture of a polymeric material and a non-polymeric material consists essentially of polymeric silicon and inorganic silicon.
Devices fabricated in accordance with embodiments of the present disclosure can be incorporated into a wide variety of electronic component modules (or units) that can be incorporated into a variety of electronic products or intermediate components. Examples of such electronic products or intermediate components include display screens, lighting devices such as discrete light source devices or lighting panels, etc. that can be utilized by the end-user product manufacturers. Such electronic component modules can optionally include the driving electronics and/or power source(s). Devices fabricated in accordance with embodiments of the present disclosure can be incorporated into a wide variety of consumer products that have one or more of the electronic component modules (or units) incorporated therein. A consumer product comprising an OLED that includes the compound of the present disclosure in the organic layer in the OLED is disclosed. Such consumer products would include any kind of products that include one or more light source(s) and/or one or more of some type of visual displays. Some examples of such consumer products include flat panel displays, curved displays, computer monitors, medical monitors, televisions, billboards, lights for interior or exterior illumination and/or signaling, heads-up displays, fully or partially transparent displays, flexible displays, rollable displays, foldable displays, stretchable displays, laser printers, telephones, mobile phones, tablets, phablets, personal digital assistants (PDAs), wearable devices, laptop computers, digital cameras, camcorders, viewfinders, micro-displays (displays that are less than 2 inches diagonal), 3-D displays, virtual reality or augmented reality displays, vehicles, video walls comprising multiple displays tiled together, theater or stadium screen, a light therapy device, and a sign. Various control mechanisms may be used to control devices fabricated in accordance with the present disclosure, including passive matrix and active matrix. Many of the devices are intended for use in a temperature range comfortable to humans, such as 18 degrees C. to 30 degrees C., and more preferably at room temperature (20-25° C.), but could be used outside this temperature range, for example, from −40 degree C. to +80° C.
More details on OLEDs, and the definitions described above, can be found in U.S. Pat. No. 7,279,704, which is incorporated herein by reference in its entirety.
The materials and structures described herein may have applications in devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may employ the materials and structures. More generally, organic devices, such as organic transistors, may employ the materials and structures.
In some embodiments, the OLED has one or more characteristics selected from the group consisting of being flexible, being rollable, being foldable, being stretchable, and being curved. In some embodiments, the OLED is transparent or semi-transparent. In some embodiments, the OLED further comprises a layer comprising carbon nanotubes.
In some embodiments, the OLED further comprises a layer comprising a delayed fluorescent emitter. In some embodiments, the OLED comprises a RGB pixel arrangement or white plus color filter pixel arrangement. In some embodiments, the OLED is a mobile device, a hand held device, or a wearable device. In some embodiments, the OLED is a display panel having less than 10 inch diagonal or 50 square inch area. In some embodiments, the OLED is a display panel having at least 10 inch diagonal or 50 square inch area. In some embodiments, the OLED is a lighting panel.
In some embodiments, the compound can be an emissive dopant. In some embodiments, the compound can produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence, i.e., TADF (also referred to as E-type delayed fluorescence; see, e.g., U.S. application Ser. No. 15/700,352, which is hereby incorporated by reference in its entirety), triplet-triplet annihilation, or combinations of these processes. In some embodiments, the emissive dopant can be a racemic mixture, or can be enriched in one enantiomer. In some embodiments, the compound can be homoleptic (each ligand is the same). In some embodiments, the compound can be heteroleptic (at least one ligand is different from others). When there are more than one ligand coordinated to a metal, the ligands can all be the same in some embodiments. In some other embodiments, at least one ligand is different from the other ligands. In some embodiments, every ligand can be different from each other. This is also true in embodiments where a ligand being coordinated to a metal can be linked with other ligands being coordinated to that metal to form a tridentate, tetradentate, pentadentate, or hexadentate ligands. Thus, where the coordinating ligands are being linked together, all of the ligands can be the same in some embodiments, and at least one of the ligands being linked can be different from the other ligand(s) in some other embodiments.
In some embodiments, the compound can be used as a phosphorescent sensitizer in an OLED where one or multiple layers in the OLED contains an acceptor in the form of one or more fluorescent and/or delayed fluorescence emitters. In some embodiments, the compound can be used as one component of an exciplex to be used as a sensitizer. As a phosphorescent sensitizer, the compound must be capable of energy transfer to the acceptor and the acceptor will emit the energy or further transfer energy to a final emitter. The acceptor concentrations can range from 0.001% to 100%. The acceptor could be in either the same layer as the phosphorescent sensitizer or in one or more different layers. In some embodiments, the acceptor is a TADF emitter. In some embodiments, the acceptor is a fluorescent emitter. In some embodiments, the emission can arise from any or all of the sensitizer, acceptor, and final emitter.
According to another aspect, a formulation comprising the compound described herein is also disclosed.
The OLED disclosed herein can be incorporated into one or more of a consumer product, an electronic component module, and a lighting panel. The organic layer can be an emissive layer and the compound can be an emissive dopant in some embodiments, while the compound can be a non-emissive dopant in other embodiments.
In yet another aspect of the present disclosure, a formulation that comprises the novel compound disclosed herein is described. The formulation can include one or more components selected from the group consisting of a solvent, a host, a hole injection material, hole transport material, electron blocking material, hole blocking material, and an electron transport material, disclosed herein.
The present disclosure encompasses any chemical structure comprising the novel compound of the present disclosure, or a monovalent or polyvalent variant thereof. In other words, the inventive compound, or a monovalent or polyvalent variant thereof, can be a part of a larger chemical structure. Such chemical structure can be selected from the group consisting of a monomer, a polymer, a macromolecule, and a supramolecule (also known as supermolecule). As used herein, a “monovalent variant of a compound” refers to a moiety that is identical to the compound except that one hydrogen has been removed and replaced with a bond to the rest of the chemical structure. As used herein, a “polyvalent variant of a compound” refers to a moiety that is identical to the compound except that more than one hydrogen has been removed and replaced with a bond or bonds to the rest of the chemical structure. In the instance of a supramolecule, the inventive compound can also be incorporated into the supramolecule complex without covalent bonds.
The materials described herein as useful for a particular layer in an organic light emitting device may be used in combination with a wide variety of other materials present in the device. For example, emissive dopants disclosed herein may be used in conjunction with a wide variety of hosts, transport layers, blocking layers, injection layers, electrodes and other layers that may be present. The materials described or referred to below are non-limiting examples of materials that may be useful in combination with the compounds disclosed herein, and one of skill in the art can readily consult the literature to identify other materials that may be useful in combination.
A charge transport layer can be doped with conductivity dopants to substantially alter its density of charge carriers, which will in turn alter its conductivity. The conductivity is increased by generating charge carriers in the matrix material, and depending on the type of dopant, a change in the Fermi level of the semiconductor may also be achieved. Hole-transporting layer can be doped by p-type conductivity dopants and n-type conductivity dopants are used in the electron-transporting layer.
Non-limiting examples of the conductivity dopants that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: EP01617493, EP01968131, EP2020694, EP2684932, US20050139810, US20070160905, US20090167167, US2010288362, WO06081780, WO2009003455, WO2009008277, WO2009011327, WO2014009310, US2007252140, US2015060804, US20150123047, and US2012146012.
A hole injecting/transporting material to be used in the present disclosure is not particularly limited, and any compound may be used as long as the compound is typically used as a hole injecting/transporting material. Examples of the material include, but are not limited to: a phthalocyanine or porphyrin derivative; an aromatic amine derivative; an indolocarbazole derivative; a polymer containing fluorohydrocarbon; a polymer with conductivity dopants; a conducting polymer, such as PEDOT/PSS; a self-assembly monomer derived from compounds such as phosphonic acid and silane derivatives; a metal oxide derivative, such as MoOx; a p-type semiconducting organic compound, such as 1,4,5,8,9,12-Hexaazatriphenylenehexacarbonitrile; a metal complex, and a cross-linkable compounds.
Examples of aromatic amine derivatives used in HIL or HTL include, but not limit to the following general structures:
Each of Ar1 to Ar9 is selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Each Ar may be unsubstituted or may be substituted by a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In one aspect, Ar1 to Ar9 is independently selected from the group consisting of:
wherein k is an integer from 1 to 20; X101 to X108 is C (including CH) or N; Z101 is NAr1, O, or S; Ar1 has the same group defined above.
Examples of metal complexes used in HIL or HTL include, but are not limited to the following general formula:
wherein Met is a metal, which can have an atomic weight greater than 40; (Y101-Y102) is a bidentate ligand, Y101 and Y102 are independently selected from C, N, O, P, and S; L101 is an ancillary ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.
In one aspect, (Y101-Y102) is a 2-phenylpyridine derivative. In another aspect, (Y101-Y102) is a carbene ligand. In another aspect, Met is selected from Ir, Pt, Os, and Zn. In a further aspect, the metal complex has a smallest oxidation potential in solution vs. Fc+/Fc couple less than about 0.6 V.
Non-limiting examples of the HIL and HTL materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN102702075, DE102012005215, EP01624500, EP01698613, EP01806334, EP01930964, EP01972613, EP01997799, EP02011790, EP02055700, EP02055701, EP1725079, EP2085382, EP2660300, EP650955, JP07-073529, JP2005112765, JP2007091719, JP2008021687, JP2014-009196, KR20110088898, KR20130077473, TW201139402, U.S. Ser. No. 06/517,957, US20020158242, US20030162053, US20050123751, US20060182993, US20060240279, US20070145888, US20070181874, US20070278938, US20080014464, US20080091025, US20080106190, US20080124572, US20080145707, US20080220265, US20080233434, US20080303417, US2008107919, US20090115320, US20090167161, US2009066235, US2011007385, US20110163302, US2011240968, US2011278551, US2012205642, US2013241401, US20140117329, US2014183517, U.S. Pat. Nos. 5,061,569, 5,639,914, WO05075451, WO07125714, WO08023550, WO08023759, WO2009145016, WO2010061824, WO2011075644, WO2012177006, WO2013018530, WO2013039073, WO2013087142, WO2013118812, WO2013120577, WO2013157367, WO2013175747, WO2014002873, WO2014015935, WO2014015937, WO2014030872, WO2014030921, WO2014034791, WO2014104514, WO2014157018.
An electron blocking layer (EBL) may be used to reduce the number of electrons and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies, and/or longer lifetime, as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than the emitter closest to the EBL interface. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than one or more of the hosts closest to the EBL interface. In one aspect, the compound used in EBL contains the same molecule or the same functional groups used as one of the hosts described below.
The light emitting layer of the organic EL device of the present disclosure preferably contains at least a metal complex as light emitting material, and may contain a host material using the metal complex as a dopant material. Examples of the host material are not particularly limited, and any metal complexes or organic compounds may be used as long as the triplet energy of the host is larger than that of the dopant. Any host material may be used with any dopant so long as the triplet criteria is satisfied.
Examples of metal complexes used as host are preferred to have the following general formula:
wherein Met is a metal; (Y103-Y104) is a bidentate ligand, Y103 and Y104 are independently selected from C, N, O, P, and S; L101 is an another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.
In one aspect, the metal complexes are:
wherein (O—N) is a bidentate ligand, having metal coordinated to atoms O and N.
In another aspect, Met is selected from Ir and Pt. In a further aspect, (Y103-Y104) is a carbene ligand.
In one aspect, the host compound contains at least one of the following groups selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Each option within each group may be unsubstituted or may be substituted by a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In one aspect, the host compound contains at least one of the following groups in the molecule:
wherein R101 is selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. k is an integer from 0 to 20 or 1 to 20. X101 to X108 are independently selected from C (including CH) or N. Z101 and Z102 are independently selected from NR101, O, or S.
Non-limiting examples of the host materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: EP2034538, EP2034538A, EP2757608, JP2007254297, KR20100079458, KR20120088644, KR20120129733, KR20130115564, TW201329200, US20030175553, US20050238919, US20060280965, US20090017330, US20090030202, US20090167162, US20090302743, US20090309488, US20100012931, US20100084966, US20100187984, US2010187984, US2012075273, US2012126221, US2013009543, US2013105787, US2013175519, US2014001446, US20140183503, US20140225088, US2014034914, U.S. Pat. No. 7,154,114, WO2001039234, WO2004093207, WO2005014551, WO2005089025, WO2006072002, WO2006114966, WO2007063754, WO2008056746, WO2009003898, WO2009021126, WO2009063833, WO2009066778, WO2009066779, WO2009086028, WO2010056066, WO2010107244, WO2011081423, WO2011081431, WO2011086863, WO2012128298, WO2012133644, WO2012133649, WO2013024872, WO2013035275, WO2013081315, WO2013191404, WO2014142472, US20170263869, US20160163995, U.S. Pat. No. 9,466,803,
One or more additional emitter dopants may be used in conjunction with the compound of the present disclosure. Examples of the additional emitter dopants are not particularly limited, and any compounds may be used as long as the compounds are typically used as emitter materials. Examples of suitable emitter materials include, but are not limited to, compounds which can produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence, i.e., TADF (also referred to as E-type delayed fluorescence), triplet-triplet annihilation, or combinations of these processes.
Non-limiting examples of the emitter materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN103694277, CN1696137, EB01238981, EP01239526, EP01961743, EP1239526, EP1244155, EP1642951, EP1647554, EP1841834, EP1841834B, EP2062907, EP2730583, JP2012074444, JP2013110263, JP4478555, KR1020090133652, KR20120032054, KR20130043460, TW201332980, U.S. Ser. No. 06/699,599, U.S. Ser. No. 06/916,554, US20010019782, US20020034656, US20030068526, US20030072964, US20030138657, US20050123788, US20050244673, US2005123791, US2005260449, US20060008670, US20060065890, US20060127696, US20060134459, US20060134462, US20060202194, US20060251923, US20070034863, US20070087321, US20070103060, US20070111026, US20070190359, US20070231600, US2007034863, US2007104979, US2007104980, US2007138437, US2007224450, US2007278936, US20080020237, US20080233410, US20080261076, US20080297033, US200805851, US2008161567, US2008210930, US20090039776, US20090108737, US20090115322, US20090179555, US2009085476, US2009104472, US20100090591, US20100148663, US20100244004, US20100295032, US2010102716, US2010105902, US2010244004, US2010270916, US20110057559, US20110108822, US20110204333, US2011215710, US2011227049, US2011285275, US2012292601, US20130146848, US2013033172, US2013165653, US2013181190, US2013334521, US20140246656, US2014103305, U.S. Pat. Nos. 6,303,238, 6,413,656, 6,653,654, 6,670,645, 6,687,266, 6,835,469, 6,921,915, 7,279,704, 7,332,232, 7,378,162, 7,534,505, 7,675,228, 7,728,137, 7,740,957, 7,759,489, 7,951,947, 8,067,099, 8,592,586, 8,871,361, WO06081973, WO06121811, WO07018067, WO07108362, WO07115970, WO07115981, WO08035571, WO2002015645, WO2003040257, WO2005019373, WO2006056418, WO2008054584, WO2008078800, WO2008096609, WO2008101842, WO2009000673, WO2009050281, WO2009100991, WO2010028151, WO2010054731, WO2010086089, WO2010118029, WO2011044988, WO2011051404, WO2011107491, WO2012020327, WO2012163471, WO2013094620, WO2013107487, WO2013174471, WO2014007565, WO2014008982, WO2014023377, WO2014024131, WO2014031977, WO2014038456, WO2014112450.
A hole blocking layer (HBL) may be used to reduce the number of holes and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies and/or longer lifetime as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and/or higher triplet energy than the emitter closest to the HBL interface. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and/or higher triplet energy than one or more of the hosts closest to the HBL interface.
In one aspect, compound used in HBL contains the same molecule or the same functional groups used as host described above.
In another aspect, compound used in HBL contains at least one of the following groups in the molecule:
wherein k is an integer from 1 to 20; L101 is another ligand, k′ is an integer from 1 to 3.
Electron transport layer (ETL) may include a material capable of transporting electrons. Electron transport layer may be intrinsic (undoped), or doped. Doping may be used to enhance conductivity. Examples of the ETL material are not particularly limited, and any metal complexes or organic compounds may be used as long as they are typically used to transport electrons.
In one aspect, compound used in ETL contains at least one of the following groups in the molecule:
wherein R101 is selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. Ar1 to Ar3 has the similar definition as Ar's mentioned above. k is an integer from 1 to 20. X101 to X108 is selected from C (including CH) or N.
In another aspect, the metal complexes used in ETL contains, but not limit to the following general formula:
wherein (O—N) or (N—N) is a bidentate ligand, having metal coordinated to atoms O, N or N, N; L101 is another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal.
Non-limiting examples of the ETL materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN103508940, EP01602648, EP01734038, EP01956007, JP2004-022334, JP2005149918, JP2005-268199, KR0117693, KR20130108183, US20040036077, US20070104977, US2007018155, US20090101870, US20090115316, US20090140637, US20090179554, US2009218940, US2010108990, US2011156017, US2011210320, US2012193612, US2012214993, US2014014925, US2014014927, US20140284580, U.S. Pat. Nos. 6,656,612, 8,415,031, WO2003060956, WO2007111263, WO2009148269, WO2010067894, WO2010072300, WO2011074770, WO2011105373, WO2013079217, WO2013145667, WO2013180376, WO2014104499, WO2014104535,
h) Charge generation layer (CGL)
In tandem or stacked OLEDs, the CGL plays an essential role in the performance, which is composed of an n-doped layer and a p-doped layer for injection of electrons and holes, respectively. Electrons and holes are supplied from the CGL and electrodes. The consumed electrons and holes in the CGL are refilled by the electrons and holes injected from the cathode and anode, respectively; then, the bipolar currents reach a steady state gradually. Typical CGL materials include n and p conductivity dopants used in the transport layers.
In any above-mentioned compounds used in each layer of the OLED device, the hydrogen atoms can be partially or fully deuterated. The minimum amount of hydrogen of the compound being deuterated is selected from the group consisting of 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, 99%, and 100%. Thus, any specifically listed substituent, such as, without limitation, methyl, phenyl, pyridyl, etc. may be undeuterated, partially deuterated, and fully deuterated versions thereof. Similarly, classes of substituents such as, without limitation, alkyl, aryl, cycloalkyl, heteroaryl, etc. also may be undeuterated, partially deuterated, and fully deuterated versions thereof.
It is understood that the various embodiments described herein are by way of example only and are not intended to limit the scope of the invention. For example, many of the materials and structures described herein may be substituted with other materials and structures without deviating from the spirit of the invention. The present invention as claimed may therefore include variations from the particular examples and preferred embodiments described herein, as will be apparent to one of skill in the art. It is understood that various theories as to why the invention works are not intended to be limiting.
Experimental Data
A 3 L flask was charged with 2-fluorophenylboronic acid (58.3 g, 417 mmol, 1.5 equiv), 2-bromo-4-methyl-phenol (52 g, 278 mmol, 1.0 equiv), potassium carbonate (77 g, 556 mmol, 2.0 equiv), acetone (1.3 L) and water (250 mL). The suspension was sparged with nitrogen for 25 minutes. Palladium(II) acetate (6.3 g, 27.8 mmol, 0.1 equiv) was added then the reaction mixture heated at reflux for 18 hours. GCMS analysis indicated that all boronic acid had been consumed. The reaction mixture was cooled to room temperature, the layers separated, and the organic layer dried over sodium sulfate. The mixture was filtered through silica gel (200 g) and the pad rinsed with ethyl acetate (2×100 mL). The filtrates were concentrated under reduced pressure. The residue was chromatographed on silica gel (750 g), eluting with 30-60% dichloromethane in heptanes. Product containing fractions were combined and concentrated under reduced pressure to give 2′-fluoro-5-methyl-[1,1′-biphenyl]-2-ol (20 g, 32% yield, 90% purity) as a pale yellow oil.
2′-Fluoro-5-methyl-[1,1′-biphenyl]-2-ol (20 g, 99 mol, 1.0 equiv) was dissolved in acetonitrile (400 mL) then N-bromosuccinimide (17.6 g, 99 mmol, 1.0 equiv) was added portion wise over 30 minutes. After addition, the reaction mixture was stirred at room temperature for 18 hours. GCMS analysis showed complete conversion to product. The reaction mixture was concentrated under reduced pressure and the residue suspended in 30% dichloromethane in hexanes (200 mL). The suspension was filtered through silica gel (150 g) and the pad rinsed with 30% dichloromethane in hexanes (800 mL). The filtrates were concentrated under reduced pressure to give 3-bromo-2′-fluoro-5-methyl-[1,1′-biphenyl]-2-ol (25.2 g, 83% yield, 92% purity) as a pale yellow oil.
To a nitrogen sparged solution of 3-bromo-2′-fluoro-5-methyl-[1,1′-biphenyl]-2-ol (17.4 g, 61.9 mmol, 1.0 equiv) in N-methyl-2-pyrrolidone (280 mL) was added powdered potassium carbonate (17.3 g, 125 mmol, 2.02 equiv) and the reaction mixture heated at 105° C. After 16 hours, LCMS analysis indicated the reaction was complete. The cooled mixture was poured into water (1 L) and ethyl acetate (700 mL). The layers were separated and the aqueous layer extracted with ethyl acetate (3×500 mL). The combined organic layers were washed with saturated brine (2×700 mL), dried over sodium sulfate, filtered and concentrated under reduced pressure. The residue was dry loaded onto silica gel (76 g) and purified on an Interchim automated chromatography system (330 g silica gel cartridge), eluting with 5-20% dichloromethane in hexanes. Product fractions were combined to give 4-bromo-2-methyldibenzo[b,d]furan (10.4 g, 64% yield, 99.9% LCMS purity).
A solution of 4-bromo-2-methyldibenzo[b,d]furan (6 g, 22.9 mmol, 1.0 equiv), bis(pinacolato)diboron (8.75 g, 34.5 mmol, 1.5 equiv) and potassium acetate (4.5 g, 46 mmol, 2.0 equiv) in 1,4-dioxane (120 mL) was sparged with nitrogen for 20 minutes. 1,1′-Dichlorobis(diphenylphosphinoferrocene)palladium (II) dichloromethane adduct (950 mg, 1.1 mmol, 0.05 equiv) was added and sparging continued for 5 minutes. The reaction mixture was heated at reflux for 18 hours, at which time GCMS analysis showed complete conversion to product. The reaction mixture was cooled and passed through a pad of silica gel (30 g), rinsing the pad with toluene (70 mL). The filtrate was dry loaded onto Celite (50 g) and the material chromatographed on silica gel (200 g), eluting with 3% ethyl acetate in hexanes. Product containing fractions were combined and concen-trated under reduced pressure to give 4,4,5,5-tetramethyl-2-(2-methyldibenzo[b,d]furan-4-yl)-1,3,2-dioxaborolane (6.0 g, 85% yield, >95% purity) as a yellow glass.
To a solution of 4,4,5,5-tetramethyl-2-(2-methyldibenzo[b,d]furan-4-yl)-1,3,2-dioxa-borolane (4.65 g, 15.1 mmol, 1.0 equiv) and 1,6-dichloroisoquinoline (3.3 g, 16.7 mmol, 1.1 equiv) in 1.4-dioxane (100 mL) was added 2.0 M aqueous potassium carbonate (15 mL, 30.2 mmol, 2.0 equiv). The mixture was sparged with nitrogen for 10 minutes. Trans-dichlorobis(triphenylphosphine)palladium(II) (320 mg, 4.5 mmol, 0.03 equiv) was added and the reaction mixture heated at reflux for 8 hours. GCMS analysis showed complete consumption of starting materials. The mixture was allowed to cool to room temperature overnight during which time the product precipitated. The suspension was filtered and the solid washed with water (3×10 mL) then acetonitrile (3×10 mL). The solids were treated with toluene (70 mL), then concentrated to dryness to give 2021-1-1024-5 (3.8 g). The filtrates were dry loaded onto Celite (50 g) and the material chromatographed on and Interchim automated chromatography system (80 g silica gel cartridge), eluting with 0-40% ethyl acetate in hexanes. Product containing fractions were combined with the precipitated solid (3.8 g) and concentrated under reduced pressure to give 6-chloro-1-(2-methyldibenzo[b,d]furan-4-yl)isoquinoline (4.51 g, 85% yield, 98% purity) as a white solid.
A solution of 6-chloro-1-(2-methyldibenzo[b,d]furan-4-yl)isoquinoline (4.3 g, 12.5 mmol, 1.0 equiv) in anhydrous tetrahydrofuran (86 mL) was sparged with nitrogen for 10 minutes. Palladium(II) acetate (84 mg, 0.38 mmol, 0.03 equiv) and 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (SPhos) (308 mg, 0.75 mmol, 0.06 equiv) were added, then the reaction mixture warmed to 30° C. while sparging with nitrogen. 0.5 M 2-Methylpropylzinc(II) bromide solution in tetrahydrofuran (31 mL, 15 mmol, 1.2 equiv) was added slowly, keeping the reaction temperature below 45° C. Once addition was complete, the reaction mixture was heated at 50° C. for 30 minutes, at which time the solution had darkened. LCMS and NMR analyses showed complete conversion of starting chloride. The reaction mixture was cooled then quenched by addition of a 1:2 mixture of saturated aqueous sodium sulfite and saturated aqueous sodium carbonate (75 mL). The mixture was stirred for 30 minutes then filtered through a pad of Celite (50 g). The pad was washed with ethyl acetate (3×30 mL) and the layers of the filtrate separated. The organic layer was washed with saturated brine (2×10 mL) and the aqueous layers were extracted with ethyl acetate (3×10 mL). The combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure. The black oily residue was purified by column chromatography, eluting with 0-30% ethyl acetate in heptanes. Product containing fractions were combined and concentrated under reduced pressure to give 6-isobutyl-1-(2-methyldibenzo[b,d]furan-4-yl) isoquinoline (3.75 g, 80% yield, >99% purity) as a pale yellow, sticky amorphous material.
A solution of 6-isobutyl-1-(2-methyldibenzo[b,d]furan-4-yl)isoquinoline (3.0 g, 8.24 mmol, 2.0 equiv) in 2-ethoxyethanol (45 mL) and water (15 mL) was sparged with nitrogen for 15 minutes. Iridium(III) chloride hydrate (1.5 g, 4.1 mmol, 1.0 equiv) was added then the reaction mixture heated at 75° C. for 18 hours. 1H NMR analysis indicated the reaction was ˜40% complete. Sodium bicarbonate powder (300 mg, 4.1 mmol, 1.0 equiv) was added, and the reaction mixture heated at 75° C. for 8 hours then cooled to room temperature overnight. The suspension was filtered and the solids washed with water (3×10 mL), then methanol (3×10 mL). The solid was air dried to give di-μ-chloro-tetrakis[(6-isobutyl-1-(2-methyldibenzo[b,d]furan-4-yl)-3′-yl)isoquinolin-2-yl]diiridium(III) (3.2 g, 83% yield) as a red solid.
To a solution of di-μ-chloro-tetrakis[(6-isobutyl-1-(2-methyldibenzo[b,d]furan-4-yl)-3′-yl)isoquinolin-2-yl]diiridium(III) (3 g, 1.57 mmol, 1.0 equiv) in a 1:1 mixture of dichloromethane and methanol (60 mL) was added 3,7-diethyl-4,6-heptandione (1 g, 4.72 mmol, 3.0 equiv) and the mixture was sparged with nitrogen for 5 minutes. Powdered potassium carbonate (870 mg, 6.29 mmol, 4.0 equiv) was added then the reaction mixture was stirred at room temperature in a flask wrapped in foil to exclude light. After 18 hours, 1H NMR analysis indicated the reaction was complete. Methanol (100 mL) was added and the slurry stirred for 30 minutes. The suspension was filtered and the solid washed with methanol (3×10 mL). The residue (3.6 g) was dissolved in dichloromethane (150 mL) and dry-loaded onto basic alumina (60 g). The crude material was chromatographed eluting with a gradient of 5-50% dichloromethane in hexanes. Cleanest product containing fractions were concentrated under reduced pressure to give bis[(6-isobutyl-1-(2-methyldibenzo[b,d]furan-4-yl)-3′-yl)isoquinolin-2-yl]-(3,7-diethyl-4,6-nonane-dionato-k2O,O′)iridium(III), Comparative example 1 (1.62 g, 45% yield, 99.9% purity) as a red solid.
A mixture of 1-fluoro-4-methyl-2-nitrobenzene (10 g, 64.5 mmol, 1.0 equiv), 2-bromo-5-fluorophenol (12.93 g, 67.7 mmol, 1.05 equiv) and potassium carbonate (17.82 g, 129 mmol, 2.0 equiv) in N,N-dimethylacetamide (300 mL) was heated at 120° C. for 2 hours. GCMS analysis indicated the reaction was complete. The reaction mixture was cooled to room temperature then diluted with water (1 L) and ethyl acetate (500 mL). The layers were separated and the aqueous layer extracted with ethyl acetate (3×500 mL). The combined organic layers were washed with saturated aqueous sodium bicarbonate (250 mL), distilled water (5×250 mL) and saturated brine (250 mL). The organic layer was filtered through a pad of sodium sulfate (˜50 g) and concentrated under reduced pressure. A solution of the residue in dichloromethane (50 mL) was adsorbed onto silica gel and purified by column chromatography, eluting with a gradient of 5-40% dichloro-methane in hexanes. Product fractions were concentrated under reduced pressure and the residue dried under high vacuum at 50° C. overnight to give 1-bromo-4-fluoro-2-(4-methyl-2-nitrophenoxy)benzene (20 g, 94% yield, 98.5% purity) as a white solid.
A mixture of 1-bromo-4-fluoro-2-(4-methyl-2-nitrophenoxy)benzene (18 g, 55.2 mmol, 1.0 equiv), sodium carbonate (7.02 g, 66.2 mmol, 1.2 equiv) and palladium(II) acetate (1.24 g, 5.52 mmol, 0.1 equiv) in N,N-dimethylacetamide (200 mL) was sparged with nitrogen for 15 minutes then heated at 165° C. for 4 hours. GCMS analysis indicated the reaction was complete. The reaction mixture was cooled to room temperature and poured into vigorously stirred water (1 L). A dark brown precipitate formed which was filtered. A solution of the solid in dichloromethane (500 mL) was filtered through a pad of Celite® (˜50 g) layered over silica gel (˜50 g), rinsing with dichloromethane (150 mL). The filtrate was concentrated under reduced pressure. The residue was dried overnight under high vacuum at 50° C. to give 7-fluoro-2-methyl-4-nitrodibenzo[b,d]furan (12.86 g, 94% yield, 99.0% purity) as an off-white solid.
A suspension of 7-fluoro-2-methyl-4-nitrodibenzo[b,d]furan (11.4 g, 46.5 mmol, 1.0 equiv) and iron powder (48 g, 860 mmol, 18.5 equiv) in acetic acid (600 mL) was heated at 60° C. for 6 hours using an overhead stirrer. GCMS analysis indicated the reaction was complete. The reaction mixture was cooled to room temperature and most acetic acid removed under reduced pressure. The residue was diluted with ethyl acetate (1 L) and the suspension filtered through a pad of Celite® (˜50 g) layered over silica gel (˜50 g), rinsing with ethyl acetate (500 mL). The filtrate was washed with saturated aqueous sodium bicarbonate (˜1 L), dried over sodium sulfate, filtered and concentrated under reduced pressure. A solution of the brown residue was adsorbed onto silica gel (100 g) and purified by column chromatography, eluting with 7-40% ethyl acetate in hexane. Product fractions were concentrated under reduced pressure to give 7-fluoro-2-methyldibenzo[b,d]furan-4-amine (8.3 g, 80% yield, 96% purity) as a white solid.
To a solution of copper(I) bromide (2.00 g, 13.94 mmol, 1.0 equiv) in acetonitrile (100 mL) was added tert-butyl nitrite (4.42 mL, 33.5 mmol, 2.4 equiv) at room temperature. A solution of 7-fluoro-2-methyldibenzo[b,d]furan-4-amine (3 g, 13.94 mmol, 1.0 equiv) in acetonitrile (25 mL) was added dropwise then the reaction mixture heated at 60° C. for 7 hours. The reaction mixture was cooled to room temper-ature and diluted with water (50 mL). The layers were separated and the aqueous layer extracted with ethyl acetate (2×50 mL). The combined organic layers were washed with distilled water (100 mL) and saturated brine (100 mL). The organic layer was filtered through a pad of sodium sulfate and concentrated under reduced pressure. A solution of the residue in dichloromethane (25 mL), was adsorbed onto Celite® (25 g) and purified by column chromatography, eluting with a gradient of 2-30% ethyl acetate in hexanes. Product fractions were concentrated under reduced pressure then the residue dried under high vacuum at 50° C. for 2 hours to give 4-bromo-7-fluoro-2-methyldibenzo[b,d]furan (2.71 g, 66% yield, 95.2% purity) as an orange solid.
A mixture of 4-bromo-7-fluoro-2-methyl-dibenzo[b,d]furan (2.71 g, 9.71 mmol, 1.0 equiv), bis(pinacolato)diboron (3.7 g, 14.56 mmol, 1.5 equiv), potassium acetate (2.38 g, 27.27 mmol, 2.5 equiv) and bis(diphenylphosphinoferrocene)palladium(II) dichloride-dichloromethane adduct (0.4 g, 0.49 mmol, 0.05 equiv) in 1,4-dioxane (70 mL) was sparged with nitrogen for 15 minutes then heated at 95° C. overnight. GCMS analysis of the reaction mixture showed the reaction was complete. The reaction mixture was cooled to room temperature. Water (15 mL), potassium carbonate (4.03 g, 29.2 mmol, 3.0 equiv), 1,6-dichloroisoquinoline (2.31 g, 11.66 mmol, 1.2 equiv) and chloro(2-di-cyclohexylphosphino-2′,6′-dimethoxy-1,1′-biphenyl)[2-(2′-amino-1,1′-biphenyl)]-palladium(II) (SphosPdG2) (0.35 g, 0.486 mmol, 0.05 equiv) were sequentially added. The reaction mixture was sparged with nitrogen for 5 minutes then heated at 80° C. overnight. The cooled reaction mixture was diluted with water (25 mL) and ethyl acetate (25 mL). The layers were separated and the aqueous layer extracted with ethyl acetate (2×25 mL). The combined organic layers were washed with distilled water (50 mL) and saturated brine (50 mL), filtered through a pad of sodium sulfate and concentrated under reduced pressure. A solution of the residue in dichloromethane (25 mL) was adsorbed onto silica gel (60 g) and purified by column chromatography, eluting with a gradient of 2-40% ethyl acetate in hexanes. Product fractions were concentrated under reduced pressure. The residue was dried under high vacuum at 50° C. for 2 hours to give, 6-chloro-1-(7-fluoro-2-methyldibenzo-[b,d]furan-4-yl)isoquinoline (2.5 g, 70% yield, 98% purity) as an off-white solid.
A mixture of 6-chloro-1-(7-fluoro-2-methyldibenzo[b,d]furan-4-yl)isoquin-oline (2.5 g, 6.91 mmol, 1.0 equiv), isobutylboronic acid (3.52 g, 34.5 mmol, 5.0 equiv), potassium carbonate (2.86 g, 20.73 mmol, 3.0 equiv), toluene (50 mL) and water (10 mL) was sparged with nitrogen for 15 minutes. Chloro(2-dicyclo-hexylphosphino-2′,6′-dimethoxy-1,1′-biphenyl)[2-(2′-amino-1,1′-biphenyl)]-palladium(II) (SphosPdG2) (0.25 g, 0.345 mmol, 0.05 equiv) was added then the reaction mixture heated at 80° C. overnight. LCMS analysis of the reaction mixture showed the reaction was complete. The reaction mixture was cooled to room temperature, diluted with water (25 mL) and extracted with ethyl acetate (3×25 mL). The combined organic layers were washed with distilled water (25 mL), and saturated brine (25 mL), filtered through a pad of sodium sulfate and concentrated under reduced pressure. A solution of the residue in dichloro-methane (15 mL) was adsorbed onto silica gel (60 g) and purified by column chromatography, eluting with a gradient of 5-40% ethyl acetate in hexanes. Product fractions were concentrated under reduced pressure. The residue was dried overnight under high vacuum at 50° C. to give 1-(7-fluoro-2-methyldibenzo[b,d]-furan-4-yl)-6-isobutylisoquinoline (2.0 g, 75% yield, 98.7% purity) as white solid.
A suspension of 1-(7-fluoro-2-methyldibenzo[b,d]furan-4-yl)-6-isobutyl-isoquinoline (1.9 g, 4.95 mmol, 2.2 equiv) and iridium(III) chloride hydrate (0.72 g, 2.274 mmol, 1.0 equiv) in triethylphosphate (35 mL) was heated at 100° C. overnight to give the intermediate μ-dichloride complex. After cooling to room temperature, 3,7-diethylnonane-4,6-dione (0.483 g, 2.274 mmol, 2.0 equiv) and powdered potassium carbonate (0.471 g, 3.41 mmol, 3.0 equiv) were added. The reaction mixture was heated at 40° C. overnight then cooled to room temperature. Water (50 mL) was added and the red solid filtered. A solution of the solid in dichloromethane (˜15 mL) was adsorbed onto silica gel and purified by column chromatography, eluting with a gradient of 7-60% dichloromethane in hexanes. Product fractions were concentrated under reduced pressure. The residue was triturated with methanol (25 mL) at room temperature, filtered and dried under high vacuum at 50° C. for overnight to give target compound (0.71 g, 25% yield, 95.0% purity) as a bright red solid. A solution of impure material (0.63 g, 95.0% purity) in dichloromethane (˜15 mL) was adsorbed onto silica gel and repurified by column chromatography, eluting with a gradient of 5-24% dichloromethane in hexanes. Product fractions were concentrated under reduced pressure. The residue was triturated with methanol (25 mL) at room temperature, filtered and dried under high vacuum at 50° C. for overnight to give bis[(1-(7-fluoro-2-methyl-dibenzo[b,d]furan-4-yl)-3′-yl)-6-isobutylisoquinolin-2-yl]-[3,7-diethyl-4,6-nonane-dionato-k2O,O′]-iridium(III), Comparative example 2, (0.51 g, 98.0% purity) as a bright red solid.
1-Bromo-2,4-difluoro-5-methylbenzene (16.56 g, 80 mmol, 1.0 equiv), bis(pinacolato)diboron (25.4 g, 100 mmol, 1.25 equiv), potassium acetate (15.70 g, 160 mmol, 2.0 equiv) and 1,4-dioxane (350 mL) were charged to a 1 L round-bottom flask equipped with a stir bar. The mixture was sparged with nitrogen for 10 minutes then bis(diphenylphosphino)ferrocenepalladium(II) dichloride-dichloromethane solvate (2.61 g, 3.20 mmol, 0.04 equiv) added. The flask was equipped with a reflux condenser, sealed with a rubber septum and purged with nitrogen for 10 minutes. The reaction mixture was heated at reflux overnight then cooled to room temperature. The reaction mixture was filtered through a pad of silica gel, eluting with ethyl acetate. The filtrate was adsorbed onto Celite® and purified by column chromatography, eluting with 0-7% ethyl acetate in hexanes. Product fractions were concentrated under reduce pressure to give 2-(2,4-difluoro-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (16.26 g, 80% yield) as a pale yellow oil.
2,6-Dibromo-4-methylphenol (13.30 g, 50 mmol, 1.0 equiv) and non-anhydrous tetrahydrofuran (200 mL) were charged to a 500 mL round bottom flask equipped with a stir bar. Sodium tert-butoxide (5.29 g, 55.0 mmol, 1.1 equiv) was added in one portion then the reaction mixture stirred at room temperature for 5 minutes. Chloro(methoxy)methane (4.64 mL, 55.0 mmol, 1.1 equiv) was added dropwise over 5 minutes then the reaction mixture stirred at room temperature for 10 minutes. TLC analysis indicated complete conversion to product. The reaction was quenched with brine and 6N aqueous sodium hydroxide. The phases were separated and the aqueous phase extracted with ethyl acetate. The combined organic phases were dried over anhydrous sodium sulfate, filtered through a pad of silica gel (25 g), eluting with ethyl acetate. The filtrate was concentrated under reduced pressure to give 1,3-dibromo-2-(methoxymethoxy)-5-methylbenzene (15.15 g, 98% yield) as a pale yellow oil.
2-(2,4-Difluoro-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxa-borolane (11.43 g, 45 mmol, 1.0 equiv), 1,3-dibromo-2-(methoxy-methoxy)-5-methylbenzene (15.00 g, 48.4 mmol, 1.075 equiv), potassium carbonate (12.44 g, 90 mmol, 2.0 equiv), 1,4-dioxane (180 mL) and water (40 mL) were charged to a 1 L round bottom flask equipped with a stir bar. The mixture was sparged with nitrogen for 10 minutes then tetrakis(triphenyl-phosphine)palladium(0) (3.12 g, 2.70 mmol, 0.06 equiv) added. The flask was equipped with a reflux condenser, sealed with a rubber septum and purged with nitrogen for 5 minutes. The reaction mixture was heated at reflux overnight then cooled to room temperature. Saturated brine and ethyl acetate were added and the phases were separated. The aqueous phase was extracted with ethyl acetate. The combined organic phases were dried over anhydrous sodium sulfate, filtered through a pad of silica gel, eluting with ethyl acetate. The filtrate was adsorbed onto Celite® and purified by column chromatography, eluting with 0-40% dichloromethane in hexanes. Product fractions were concentrated under reduced pressure to give 3-bromo-2′,4′-difluoro-2-(methoxymeth-oxy)-5,5′-dimethyl-1,1′-biphenyl (15.53 g, 62% yield, 64% purity) as a clear oil.
3-Bromo-2′,4′-difluoro-2-(methoxymethoxy)-5,5′-dimethyl-1,1′-biphenyl (15.50 g, 28.2 mmol, 1.0 equiv) and dichloromethane (170 mL) were charged to a 500 mL round-bottom flask, equipped with a stir bar, and the mixture stirred for 5 minutes. Trifluoroacetic acid (15.11 ml, 197 mmol, 7.0 equiv) was added via an addition funnel over 5 minutes, then the reaction mixture was stirred at room temperature overnight. The reaction mixture was concentrated under reduced pressure to remove excess trifluoroacetic acid then the residue diluted with dichloromethane (150 mL). The mixture was washed with saturated aqueous sodium bicarbonate and the aqueous layer extracted with dichloromethane. The combined organic layers were dried over anhydrous sodium sulfate, filtered through a pad of silica gel, eluting with 25% ethyl acetate in dichloromethane. The filtrate was concentrated under reduced pressure to give 3-bromo-2′,4′-difluoro-5,5′-dimethyl-[1,1′-bi-phenyl]-2-ol (13.70 g, 102% yield, 66% purity) as a pale yellow oil.
3-Bromo-2′,4′-difluoro-5,5′-dimethyl-[1,1′-biphenyl]-2-ol (13.70 g, 29.0 mmol, 1.0 equiv), potassium carbonate (12.02 g, 87 mmol, 3.0 equiv) and N,N-dimethylformamide (80 mL) were charged to a 250 mL round-bottom flask containing a stir bar. The flask was equipped with a reflux condenser, sealed with a rubber septum then the reaction mixture heated at 120° C. for 2 hours under nitrogen. The reaction mixture was cooled to room temperature and diluted with dichloromethane. The mixture was sequentially washed with water, 1M aqueous sodium hydroxide and brine. The organic layer was dried over anhydrous sodium sulfate, filtered through a pad of silica gel, eluting with 20% ethyl acetate in dichloro-methane. The filtrate was concentrated under reduced pressure. The residue was triturated with methanol and the solid filtered. The filtrate was adsorbed onto Celite® and purified column chromatography, eluting with 0-12% dichloromethane in hexanes. Product fractions were concentrated under reduced pressure to give 6-bromo-3-fluoro-2,8-di-methyldibenzo[b,d]furan (5.74 g, 68% yield) as a white solid.
3-Bromo-3-fluoro-2,8-dimethyldibenzo[b,d]furan (5.28 g, 18 mmol, 1.0 equiv), bis(pinacolato)diboron (5.71 g, 22.50 mmol, 1.25 equiv), potassium acetate (3.53 g, 36.0 mmol, 2.0 equiv) and 1,4-di-oxane (95 mL) were charged to a 250 mL round-bottom flask equipped with stir bar. The mixture was sparged with nitrogen for 10 minutes and bis(diphenylphos-phino)ferrocene palladium(II) dichloride-dichloromethane solvate (0.733 g, 0.900 mmol, 0.05 equiv) added. The flask was equipped with a reflux condenser, sealed with a rubber septum and purged with nitrogen for 10 minutes. The reaction mixture was heated at 100° C. overnight. Then cooled reaction mixture was filtered through a pad of silica gel, eluting with 20% ethyl acetate in dichloromethane. The filtrate was adsorbed onto Celite® and purified by column chromatography, eluting with 0:20:80 to 7:20:71 mixture of ethyl acetate, dichloromethane and hexanes. Product fractions were concentrated under reduced pressure. The residual solid was triturated with methanol and dried in a vacuum oven to give 2-(7-fluoro-2,8-dimethyldi-benzo[b,d]furan-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (4.036 g, 66% yield) as a white solid.
2-(7-Fluoro-2,8-dimethyldibenzo[b,d]furan-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (6.42 g, 18.87 mmol, 1.0 equiv), 1,6-dichloro-isoquinoline (4.48 g, 22.65 mmol, 1.2 equiv), potassium carbonate (5.22 g, 37.7 mmol, 2.0 equiv), 1,4-dioxane (100 mL) and water (20 mL) were charged to a 500 mL round bottom flask equipped with a stir bar. The mixture was sparged with nitrogen for 10 minutes then bis(triphenylphosphine)palladium(II) dichloride (0.795 g, 1.132 mmol, 0.06 equiv) added. The flask was equipped with a reflux condenser, sealed with a rubber septum and purged with nitrogen for 10 minutes. The reaction mixture was heated at reflux overnight, cooled to room temperature and diluted with acetonitrile. The solid was filtered and washed sequentially with water and acetonitrile. A solution of the solid in dichloromethane was washed with saturated brine (100 mL) and dried over anhydrous sodium sulfate. The mixture was filtered through a pad of silica gel (30 g), eluting with 25% ethyl acetate in dichloromethane (1000 mL). The filtrate was concentrated under reduced pressure to give 6-chloro-1-(7-fluoro-2,8-dimethyldibenzo[b,d]furan-4-yl)isoquinoline (5.33 g, 75% yield) as an off-white solid.
6-Chloro-1-(7-fluoro-2,8-dimethyldibenzo[b,d]furan-4-yl)iso-quinoline (5.19 g, 13.81 mmol, 1.0 equiv), isobutylboronic acid (7.04 g, 69.0 mmol, 5.0 equiv), potassium carbonate (5.73 g, 41.4 mmol, 3.0 equiv), toluene (100 mL) and water (20 mL) were charged to a 500 mL round bottom flask equipped with a stir bar. The mixture was sparged with nitrogen for 10 minutes then chloro(2-dicyclohexylphosphino-2′,6′-dimethoxy-1,1′-biphenyl)-[2-(2′-amino-1,1′-biphenyl)]palladium(II) (SPhos-Pd-G2) (0.497 g, 0.690 mmol, 0.05 equiv) added. The flask was equipped with a reflux condenser, sealed with a rubber septum and purged with nitrogen for 10 minutes. The reaction mixture was heated at 85° C. overnight, cooled to room temperature then diluted with ethyl acetate and saturated brine. The layers were separated and the aqueous layer extracted with dichloromethane. The combined organic layers were dried over anhydrous sodium sulfate, filtered through a pad of silica gel, eluting with 25% ethyl acetate in dichloromethane. The filtrate was concentrated under reduced pressure to give crude 1-(7-fluoro-2,8-dimethyldibenzo[b,d]furan-4-yl)-6-isobutylisoquinoline (˜100% yield) as an off-white solid.
A suspension of 1-(7-fluoro-2-methyldibenzo[b,d]furan-4-yl)-6-isobutyl-isoquinoline (1.9 g, 4.95 mmol, 2.2 equiv) and iridium(III) chloride hydrate (0.72 g, 2.274 mmol, 1.0 equiv) in triethylphosphate (35 mL) was heated at 100° C. overnight to give the intermediate μ-dichloride complex. After cooling to room temperature, 3,7-diethylnonane-4,6-dione (0.483 g, 2.274 mmol, 2.0 equiv) and powdered potassium carbonate (0.471 g, 3.41 mmol, 3.0 equiv) were added. The reaction mixture was heated at 40° C. overnight then cooled to room temperature. Water was added and the red solid filtered. A solution of the solid in dichloromethane was adsorbed onto silica gel and purified by column chromatography, eluting with a gradient of 7-60% dichloromethane in hexanes. Product fractions were concentrated under reduced pressure. The residue was triturated with methanol at room temperature, filtered and dried under high vacuum at 50° C. for overnight to gives a red color solid. A solution of this impure material (0.63 g, 95.0% purity) in dichloromethane was adsorbed onto silica gel (60 g) and repurified by column chromatography, eluting with a gradient of 5-24% dichloromethane in hexanes. Product fractions were concentrated under reduced pressure. The residue was triturated with methanol at room temperature, filtered and dried under high vacuum at 50° C. for overnight to give bis[(1-(7-fluoro-2-methyl-dibenzo[b,d]furan-4-yl)-3′-yl)-6-isobutylisoquinolin-2-yl]-[3,7-diethyl-4,6-nonane-dionato-k2O,O′]-iridium(III), Inventive example 1, (0.51 g, 98.0% purity) as a bright red solid.
All example devices were fabricated by high vacuum (<10-7 Torr) thermal evaporation. The anode electrode was 1200 Å of indium tin oxide (ITO). The cathode consisted of 10 Å of Liq (8-hydroxyquinoline lithium) followed by 1,000 Å of Al. All devices were encapsulated with a glass lid sealed with an epoxy resin in a nitrogen glove box (<1 ppm of H2O and O2) immediately after fabrication, and a moisture getter was incorporated inside the package. The organic stack of the device examples consisted of sequentially, from the ITO surface, 100 Å of HAT-CN as the hole injection layer (HIL); 400 Å of HTM as a hole transporting layer (HTL); 50 Å of EBM as a electron blocking layer (EBL); 400 Å of an emissive layer (EML) containing from red host RH1, 18% assistant host RH2, and 3% of emitter; and 350 Å of Liq (8-hydroxyquinoline lithium) doped with 35% of ETM as the ETL.
The chemical structures of the device materials are shown below:
Upon fabrication, the experimental devices were EL and JVL tested. For this purpose, each device was energized by a 2 channel Keysight B2902A SMU at a current density of 10 mA/cm2 and measured using Photo Research PR735 Spectroradiometer. Radiance (W/str/cm2) from 380 nm to 1080 nm, and total integrated photon count were collected. The device was then placed under a large area silicon photodiode for the JVL sweep. The integrated photon count of the device at 10 mA/cm2 is used to convert the photodiode current to photon count. The external quantum efficiency (EQE) of the devices were calculated using the total integrated photon count. Tsub is the sublimation temperature of the material. All results are summarized in Table 2.
As shown in Table 2, the Inventive Device 1 exhibited ˜3 nm red shift of peak wavelength compared to the two comparative devices. Red shift is desired for many applications requiring deep red emission color. Inventive device 1 exhibited the same device efficiency EQE as Comparative Device 1 and higher EQE than Comparative Device 2. In addition, Inventive Device 1 exhibited the lowest Tsub (300° C.) compared to both comparative devices. Lower Tsub is highly desirable property for materials used in OLED devices because it results in less expensive and simpler manufacturing process.
This application claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Application No. 63/246,472, filed on Sep. 21, 2021, the entire contents of which are incorporated herein by reference.
| Number | Date | Country | |
|---|---|---|---|
| 63246472 | Sep 2021 | US |
